ARCHIVES

BMS Demands Resignation Of Two ImClone Executives

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002